These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3033534)

  • 21. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists.
    Miaskowski C; Sutters KA; Taiwo YO; Levine JD
    Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
    Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
    Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of specific opioid receptor agonists on rat pup isolation calls.
    Carden SE; Barr GA; Hofer MA
    Brain Res Dev Brain Res; 1991 Sep; 62(1):17-22. PubMed ID: 1662121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid receptor regulation of the release of norepinephrine in brain.
    Werling LL; Brown SR; Cox BM
    Neuropharmacology; 1987 Jul; 26(7B):987-96. PubMed ID: 2821438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons.
    Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC
    Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
    Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
    Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential antagonism of mu agonists by U50,488H in the rat.
    Porreca F; Tortella FC
    Life Sci; 1987 Dec; 41(23):2511-6. PubMed ID: 2824958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kappa- and delta-opioid agonists synergize to produce potent analgesia.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 Feb; 509(1):165-8. PubMed ID: 2155044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioids modify the release of LH at the pituitary level: in vitro studies with entire rat pituitaries.
    Dragatsis I; Papazafiri P; Zioudrou C; Gerozissis K
    J Endocrinol; 1995 May; 145(2):263-70. PubMed ID: 7616159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
    Werling LL; McMahon PN; Cox BM
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of mu, delta, and kappa ligands on G protein alpha subunits in cultured brain cells.
    Vogel Z; Barg J; Attali B; Simantov R
    J Neurosci Res; 1990 Sep; 27(1):106-11. PubMed ID: 2174976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV; Johnson KJ; Proctor WR
    Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.